Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
<iframe src="https://statesidedaily.com/embed/cluster/a3d5db888b70cc11a9836b108dd17258f73ce02f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports"></iframe>
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
